Efficacy of tocilizumab in patients with COVID-19 ARDS undergoing noninvasive ventilation

BACKGROUND: The severity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is extremely variable, ranging from asymptomatic patients to those who develop severe acute respiratory distress syndrome (ARDS). As for now, there are still no really effective therapies for coronavir...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Crit Care
Hlavní autoři: Menzella, Francesco, Fontana, Matteo, Salvarani, Carlo, Massari, Marco, Ruggiero, Patrizia, Scelfo, Chiara, Barbieri, Chiara, Castagnetti, Claudia, Catellani, Chiara, Gibellini, Giorgia, Falco, Francesco, Ghidoni, Giulia, Livrieri, Francesco, Montanari, Gloria, Casalini, Eleonora, Piro, Roberto, Mancuso, Pamela, Ghidorsi, Luca, Facciolongo, Nicola
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2020
Témata:
Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7523258/
https://ncbi.nlm.nih.gov/pubmed/32993751
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13054-020-03306-6
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky